Citations 1
Reporting Essentials for DElirium bioMarker Studies (REDEEMS): Explanation and Elaboration
Amgarth‐Duff, Ingrid , Hosie, Annmarie , Olofsson, Birgitta, Steiner, Luzius A. , Vasunilashorn, Sarinnapha M. , Agar, Meera , Caplan, Gideon A. , Adamis, Dimitrios , Watne, Leiv Otto , Cunningham, Colm M. , Oh, Esther S , Wang, Sophia , Lindroth, Heidi , Sanders, Robert D. , Olofsson, Birgitta, Girard, Timothy D.
Delirium | March 7, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available
Despite many studies of potential delirium biomarkers, delirium pathophysiology remains unclear. Evidence shows that the quality of reporting delirium biomarker studies is sub-optimal. Better reporting of delirium biomarker studies is needed to understand delirium pathophysiology better. To improve robustness, transparency and uniformity of delirium biomarker study reports, the REDEEMS (Reporting Essentials for DElirium bioMarker Studies) guideline was developed by an international group of delirium researchers through a three-stage process, including a systematic review, a three-round Delphi study, and a follow-up consensus meeting. This process resulted in a 9-item guideline to inform delirium fluid biomarker studies. To enhance implementation of the REDEEMS guideline, this Explanation and Elaboration paper provides a detailed explanation of each item. We anticipate that the REDEEMS guideline will help to accelerate our understanding of delirium pathophysiology by improving the reporting of delirium biomarker research and, consequently the capacity to synthesise results across studies.